Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Other-Long-Term-Liabilities" stands at 4.13 Billion United States Dollars as of 09/30/2025.
As of the end of Novartis AG's third quarter, the item "Other Long Term Liabilities" stands at 4.13 Billion USD. This represents a decrease of -2.69 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -5.95 percent compared to the value the year prior.
The 1 year change in percent is -5.95.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Long Term Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Long Term Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Long Term Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Long Term Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Long Term Liabilities | 280,205,508,085.11 |